Impact due to Medicine and Device Issues

I write in response to your request under the Official Information Act received on 28 July 2020, and your subsequent email of 20 August 2020, for the following information. I apologise for the delay in submitting the requested information. 

Clarification Response 20 August 2020

Information in relation to COVID-19-impacted shortages and so the timeframe would be just from January 2020 till August 2020.  

OIA Request 28 July 2020

1. All correspondence and documents that reviewed or provided advice about whether there is a shortage or no stock of the following list of medicines (see list below) at Counties Manukau District Health Board's hospitals.
2. All correspondence and documents that reviewed or provided advice about how Counties Manukau DHB will be managing treatment for those who require medicines that are in short supply or where there is no stock. The following medicines and devices have been listed by Pharmac as having supply issues.

• Acarbose (Glucobay)
• Apotex
• Benzbromarone
• Cephalexin
• Chlorhexidine
• Clomipramine
• Fentanyl injections
• Fluoxetine
• Gemfibrozil discontinuation
• Labetalol injection
• Levodopa with carbidopa (Sinemet)
• Levomepromazine (Nozinan)
• Montelukast
• Morphine sulphate tablets
• Nitrazepam (discontinuation)
• Oral contraceptives
• Paracetamol
• Prochlorperazine (Buccastem)
• Propofol
• Pulmocare oral feed 1.5kcal/ml
• Ranitidine
• Suxamethonium
• Ultraproct

Files

• Impact due to medicine and device issues